UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
ICTU Global will be managing an exploratory feasibility study for UNEEG Medical. A Danish company pioneering in cognitive technologies that collect, monitor and analyse brain activity (EEG). The devices can be used for medical and diagnostic purposes within epilepsy and detect and alert people with diabetes of severe hypoglycaemia, aiming to improve patients’ quality of life.
This study will be evaluating the feasibility and useability of a CE Marked medical device (for use in epilepsy) in detecting hypoglycaemia for people with type 1 diabetes. Information regarding safety will also be collected and analysed. This study will help to explore whether the device is working as it should in patients with this condition, before proceeding with a planned larger trial.
Symptoms of hypoglycaemia can be serious. There is a need for a reliable hypoglycaemia notification system which is easy and convenient to use, and with high sensitivity and high rate of positive prediction. In Greater London there are approx. 5,000 ambulance calls every year due to acute hypoglycaemia and one in three people with type 1 diabetes lives with impaired awareness of hypoglycaemia in the Western World*
The study will be led by Professor Nick Oliver: https://www.imperial.ac.uk/people/nick.oliver
Twenty participants will be recruited in 2022 to take part in this innovative study.
*UNEEG medical estimate for EU and North America based on literature review and UK data available.